{"url":"https://lda.senate.gov/api/v1/filings/e63be703-e2f8-426b-97a1-e90daed43c0a/","filing_uuid":"e63be703-e2f8-426b-97a1-e90daed43c0a","filing_type":"3T","filing_type_display":"3rd Quarter - Termination","filing_year":2015,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e63be703-e2f8-426b-97a1-e90daed43c0a/print/","filing_document_content_type":"text/html","income":null,"expenses":"14000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Jessica Lerma","dt_posted":"2016-03-17T09:56:57.617000-04:00","termination_date":"2015-07-24","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"10100 Reunion Place","registrant_address_2":"Suite 700","registrant_different_address":false,"registrant_city":"San Antonio","registrant_state":"TX","registrant_zip":"78216","registrant":{"id":401103607,"url":"https://lda.senate.gov/api/v1/registrants/401103607/","house_registrant_id":null,"name":"CAPTURERX","description":"pharmaceutical third party administrator","address_1":"10100 Reunion Place","address_2":"Suite 700","address_3":null,"address_4":null,"city":"San Antonio","state":"TX","state_display":"Texas","zip":"78216","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTOPHER KAPSCH","contact_telephone":"+1 919-641-7268","dt_updated":"2022-04-06T16:07:19.620720-04:00"},"client":{"id":199777,"url":"https://lda.senate.gov/api/v1/clients/199777/","client_id":12,"name":"CAPTURERX","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-02-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocating on behalf of the 340B prescription drug program.  Promoting transparency and compliance within the 340B program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61744,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"KAPSCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Advocating on behalf of the 340B prescription drug program.  Promoting transparency and compliance within the 340B program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61744,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"KAPSCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}